

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 9.36810938 |
| 2 | translational termination (GO:0006415) | 8.97830067 |
| 3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 7.92288126 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 7.84604996 |
| 5 | cotranslational protein targeting to membrane (GO:0006613) | 7.83104719 |
| 6 | protein targeting to ER (GO:0045047) | 7.80275000 |
| 7 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 7.50353215 |
| 8 | translational elongation (GO:0006414) | 7.49307716 |
| 9 | protein localization to endoplasmic reticulum (GO:0070972) | 7.48122237 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 7.09822609 |
| 11 | viral life cycle (GO:0019058) | 6.95136672 |
| 12 | cellular protein complex disassembly (GO:0043624) | 6.70475210 |
| 13 | DNA deamination (GO:0045006) | 6.50051742 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 6.48776825 |
| 15 | translational initiation (GO:0006413) | 5.97702603 |
| 16 | negative regulation of cell killing (GO:0031342) | 5.95891263 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.95891263 |
| 18 | protein complex disassembly (GO:0043241) | 5.74507552 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 5.49444242 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 5.49444242 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.49444242 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.49444242 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.49444242 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 5.49444242 |
| 25 | macromolecular complex disassembly (GO:0032984) | 5.43129103 |
| 26 | protein targeting to membrane (GO:0006612) | 5.40154310 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.39711586 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 5.27092834 |
| 29 | detection of other organism (GO:0098543) | 5.23750748 |
| 30 | detection of bacterium (GO:0016045) | 5.16329163 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.13691483 |
| 32 | response to peptidoglycan (GO:0032494) | 4.97075387 |
| 33 | maturation of SSU-rRNA (GO:0030490) | 4.96407556 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91124109 |
| 35 | ribosomal large subunit biogenesis (GO:0042273) | 4.76216379 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.67589210 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 4.64606400 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 4.42083652 |
| 39 | detection of external biotic stimulus (GO:0098581) | 4.41745916 |
| 40 | translation (GO:0006412) | 4.41349198 |
| 41 | leukocyte aggregation (GO:0070486) | 4.36157720 |
| 42 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.29760070 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.25934512 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 4.23022100 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.19216385 |
| 46 | ATP synthesis coupled proton transport (GO:0015986) | 4.17712099 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.17712099 |
| 48 | neutrophil activation (GO:0042119) | 4.17353371 |
| 49 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.12843257 |
| 50 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.12308491 |
| 51 | mRNA catabolic process (GO:0006402) | 4.04896710 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 4.04524325 |
| 53 | respiratory burst (GO:0045730) | 3.96164582 |
| 54 | establishment of protein localization to membrane (GO:0090150) | 3.93513798 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.92835635 |
| 56 | granulocyte activation (GO:0036230) | 3.89746364 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87861054 |
| 58 | response to host immune response (GO:0052572) | 3.87462920 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.87462920 |
| 60 | platelet dense granule organization (GO:0060155) | 3.87060130 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.85790023 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85391351 |
| 63 | detection of biotic stimulus (GO:0009595) | 3.84055228 |
| 64 | ncRNA 3-end processing (GO:0043628) | 3.77871760 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 3.77428575 |
| 66 | protein targeting (GO:0006605) | 3.75864425 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.74679551 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.74679551 |
| 69 | response to type I interferon (GO:0034340) | 3.71171685 |
| 70 | RNA catabolic process (GO:0006401) | 3.66427361 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64418960 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61908693 |
| 73 | cellular extravasation (GO:0045123) | 3.59438133 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.57945596 |
| 75 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57020857 |
| 76 | respiratory electron transport chain (GO:0022904) | 3.50549378 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.48041283 |
| 78 | electron transport chain (GO:0022900) | 3.46702337 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.46594933 |
| 80 | response to host (GO:0075136) | 3.46594933 |
| 81 | response to host defenses (GO:0052200) | 3.46594933 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.44890025 |
| 83 | response to muramyl dipeptide (GO:0032495) | 3.43966904 |
| 84 | microglial cell activation (GO:0001774) | 3.43636982 |
| 85 | macrophage activation (GO:0042116) | 3.43606318 |
| 86 | neutrophil mediated immunity (GO:0002446) | 3.42256568 |
| 87 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.41742588 |
| 88 | establishment of protein localization to organelle (GO:0072594) | 3.39188214 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38189945 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.37423463 |
| 91 | heme biosynthetic process (GO:0006783) | 3.34738957 |
| 92 | defense response to protozoan (GO:0042832) | 3.30134263 |
| 93 | protein localization to membrane (GO:0072657) | 3.29228315 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.28539990 |
| 95 | B cell mediated immunity (GO:0019724) | 3.28254108 |
| 96 | response to interleukin-15 (GO:0070672) | 3.26921347 |
| 97 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.25719331 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24703257 |
| 99 | pseudouridine synthesis (GO:0001522) | 3.24331359 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19794672 |
| 101 | iron-sulfur cluster assembly (GO:0016226) | 3.19054462 |
| 102 | metallo-sulfur cluster assembly (GO:0031163) | 3.19054462 |
| 103 | positive regulation of mast cell activation (GO:0033005) | 3.17925372 |
| 104 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.17519525 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16252246 |
| 106 | B cell receptor signaling pathway (GO:0050853) | 3.15516892 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 3.12498441 |
| 108 | regulation of mast cell activation (GO:0033003) | 3.12188841 |
| 109 | leukocyte degranulation (GO:0043299) | 3.11035335 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09439445 |
| 111 | protein maturation by protein folding (GO:0022417) | 3.08654073 |
| 112 | inner mitochondrial membrane organization (GO:0007007) | 3.07343045 |
| 113 | germinal center formation (GO:0002467) | 3.06091155 |
| 114 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05506897 |
| 115 | cellular component biogenesis (GO:0044085) | 3.05328663 |
| 116 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.05317849 |
| 117 | cellular response to interleukin-15 (GO:0071350) | 3.04170595 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02965573 |
| 119 | lymphoid progenitor cell differentiation (GO:0002320) | 3.02322079 |
| 120 | negative regulation of type 2 immune response (GO:0002829) | 3.00655497 |
| 121 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99561245 |
| 122 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99561245 |
| 123 | regulation of neuron projection regeneration (GO:0070570) | 2.98876659 |
| 124 | regulation of axon regeneration (GO:0048679) | 2.98876659 |
| 125 | negative regulation of innate immune response (GO:0045824) | 2.98618877 |
| 126 | regulation of regulated secretory pathway (GO:1903305) | 2.97606108 |
| 127 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97497468 |
| 128 | pentose-phosphate shunt (GO:0006098) | 2.97308805 |
| 129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97213116 |
| 130 | regulation of B cell differentiation (GO:0045577) | 2.96059645 |
| 131 | regulation of tolerance induction (GO:0002643) | 2.94954850 |
| 132 | response to protozoan (GO:0001562) | 2.93684839 |
| 133 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93403636 |
| 134 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91213711 |
| 135 | positive regulation of type 2 immune response (GO:0002830) | 2.88356087 |
| 136 | regulation of antigen processing and presentation (GO:0002577) | 2.87639017 |
| 137 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.87158137 |
| 138 | termination of RNA polymerase III transcription (GO:0006386) | 2.87158137 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.86649206 |
| 140 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86119772 |
| 141 | response to interferon-beta (GO:0035456) | 2.85284725 |
| 142 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85213986 |
| 143 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.84980708 |
| 144 | protein complex biogenesis (GO:0070271) | 2.84223915 |
| 145 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83840279 |
| 146 | positive thymic T cell selection (GO:0045059) | 2.82815168 |
| 147 | positive regulation of mast cell degranulation (GO:0043306) | 2.82487204 |
| 148 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82487204 |
| 149 | regulation of type 2 immune response (GO:0002828) | 2.80567767 |
| 150 | ubiquinone biosynthetic process (GO:0006744) | 2.80205022 |
| 151 | quinone biosynthetic process (GO:1901663) | 2.80205022 |
| 152 | regulation of mitochondrial translation (GO:0070129) | 2.77786800 |
| 153 | negative regulation of interleukin-6 production (GO:0032715) | 2.77747363 |
| 154 | positive regulation of B cell differentiation (GO:0045579) | 2.77519789 |
| 155 | myeloid leukocyte activation (GO:0002274) | 2.76266694 |
| 156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.75722070 |
| 157 | respiratory chain complex IV assembly (GO:0008535) | 2.75348227 |
| 158 | GDP-mannose metabolic process (GO:0019673) | 2.73825368 |
| 159 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.72825699 |
| 160 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.70417510 |
| 161 | Peyers patch development (GO:0048541) | 2.70417510 |
| 162 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.69041079 |
| 163 | regulation of regulatory T cell differentiation (GO:0045589) | 2.66751363 |
| 164 | anterograde synaptic vesicle transport (GO:0048490) | 2.64582733 |
| 165 | regulation of oxidative phosphorylation (GO:0002082) | 2.64205282 |
| 166 | regulation of respiratory burst (GO:0060263) | 2.62631638 |
| 167 | endosome to pigment granule transport (GO:0043485) | 2.60165150 |
| 168 | endosome to melanosome transport (GO:0035646) | 2.60165150 |
| 169 | DNA damage response, detection of DNA damage (GO:0042769) | 2.59808223 |
| 170 | rRNA processing (GO:0006364) | 2.58962794 |
| 171 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.57930246 |
| 172 | protein targeting to mitochondrion (GO:0006626) | 2.57823679 |
| 173 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.54037350 |
| 174 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.54037350 |
| 175 | NADH dehydrogenase complex assembly (GO:0010257) | 2.54037350 |
| 176 | heme metabolic process (GO:0042168) | 2.51754428 |
| 177 | nucleoside salvage (GO:0043174) | 2.50072677 |
| 178 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.49855685 |
| 179 | CTP metabolic process (GO:0046036) | 2.48240222 |
| 180 | CTP biosynthetic process (GO:0006241) | 2.48240222 |
| 181 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.47445848 |
| 182 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.46701502 |
| 183 | GTP biosynthetic process (GO:0006183) | 2.44292071 |
| 184 | neuronal action potential propagation (GO:0019227) | 2.44178682 |
| 185 | rRNA metabolic process (GO:0016072) | 2.43290052 |
| 186 | mature B cell differentiation involved in immune response (GO:0002313) | 2.43260698 |
| 187 | tRNA methylation (GO:0030488) | 2.43240617 |
| 188 | purine-containing compound salvage (GO:0043101) | 2.42100647 |
| 189 | NADPH regeneration (GO:0006740) | 2.41979656 |
| 190 | establishment of protein localization to mitochondrion (GO:0072655) | 2.37776881 |
| 191 | fucosylation (GO:0036065) | 2.37514578 |
| 192 | galactose catabolic process (GO:0019388) | 2.37331634 |
| 193 | pyrimidine nucleoside salvage (GO:0043097) | 2.36032764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56721320 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31398738 |
| 3 | * SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.77075640 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.72988008 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.44809950 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.96375647 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.84339564 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.79767349 |
| 9 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.77708986 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77586190 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65619666 |
| 12 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.59444632 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.55158713 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52146692 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48043159 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.45893974 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.44628219 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43851343 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42978065 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.41143392 |
| 21 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.35098501 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.34883473 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34758646 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31079941 |
| 25 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.27444483 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26285616 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23804986 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.22906730 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.16638065 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16337369 |
| 31 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10643446 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07180426 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03225543 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00392374 |
| 35 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.00319503 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99263928 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93215732 |
| 38 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.89916584 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.89369080 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.88316973 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87654576 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86888872 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85067810 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.83941899 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82893488 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82819437 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82739660 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82505468 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75887618 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.74769619 |
| 51 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.73415800 |
| 52 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68271298 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67907809 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67488869 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66881180 |
| 56 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.65055123 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64107858 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.63973673 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.62849439 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61476564 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.59599900 |
| 62 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.58191718 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55659204 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55495878 |
| 65 | * MYB_26560356_Chip-Seq_TH1_Human | 1.54699613 |
| 66 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.53837298 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53426538 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53021687 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52577248 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50105118 |
| 71 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48909505 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48504013 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45838156 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45586777 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45518751 |
| 76 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45396147 |
| 77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45282598 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44130098 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43812789 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43751642 |
| 81 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41876851 |
| 82 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40941705 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40109970 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.39756882 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39216954 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.38432848 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36347681 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34164851 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.33810467 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33051466 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31918169 |
| 92 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31684192 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30709805 |
| 94 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30420060 |
| 95 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29544701 |
| 96 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.28180408 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27699639 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26322951 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25997129 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.25611169 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24648222 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24327038 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.22899021 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22533368 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22122591 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.21458002 |
| 107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21068579 |
| 108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20674464 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20244783 |
| 110 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19638669 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19059477 |
| 112 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16464550 |
| 113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16430754 |
| 114 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14412395 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13959965 |
| 116 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13579230 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13395352 |
| 118 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13041032 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12716703 |
| 120 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.12188752 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11014201 |
| 122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10974672 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10309107 |
| 124 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09852430 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09836149 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08635905 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07221190 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06924000 |
| 129 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.06030501 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05684251 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05323574 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04777102 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04482758 |
| 134 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.04313228 |
| 135 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03609287 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03253633 |
| 137 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02539668 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02347744 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02291999 |
| 140 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02258678 |
| 141 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01432630 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01214735 |
| 143 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00933916 |
| 144 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00840804 |
| 145 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00334288 |
| 146 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00296601 |
| 147 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99591289 |
| 148 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97524472 |
| 149 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97130968 |
| 150 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95112776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.94449469 |
| 2 | MP0005174_abnormal_tail_pigmentation | 2.84183970 |
| 3 | MP0006082_CNS_inflammation | 2.81279025 |
| 4 | MP0000685_abnormal_immune_system | 2.67394002 |
| 5 | MP0008260_abnormal_autophagy | 2.48662274 |
| 6 | MP0006036_abnormal_mitochondrial_physio | 2.44944642 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.39212867 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.32228315 |
| 9 | MP0003866_abnormal_defecation | 2.29095725 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.26928346 |
| 11 | MP0003329_amyloid_beta_deposits | 2.16084000 |
| 12 | MP0003436_decreased_susceptibility_to | 2.15498350 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.14005879 |
| 14 | MP0005671_abnormal_response_to | 2.07779749 |
| 15 | MP0009840_abnormal_foam_cell | 2.06354983 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.04525689 |
| 17 | MP0004381_abnormal_hair_follicle | 2.01036411 |
| 18 | MP0005451_abnormal_body_composition | 1.85643783 |
| 19 | MP0009785_altered_susceptibility_to | 1.82169758 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.79527802 |
| 21 | MP0002796_impaired_skin_barrier | 1.79424784 |
| 22 | MP0002405_respiratory_system_inflammati | 1.78585152 |
| 23 | MP0003724_increased_susceptibility_to | 1.72687488 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.72638624 |
| 25 | MP0005025_abnormal_response_to | 1.72499283 |
| 26 | MP0006035_abnormal_mitochondrial_morpho | 1.71292706 |
| 27 | MP0003880_abnormal_central_pattern | 1.70638045 |
| 28 | MP0009278_abnormal_bone_marrow | 1.67400762 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.61807099 |
| 30 | MP0009764_decreased_sensitivity_to | 1.57958180 |
| 31 | MP0005083_abnormal_biliary_tract | 1.57152220 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.57059353 |
| 33 | MP0004510_myositis | 1.56690561 |
| 34 | MP0004147_increased_porphyrin_level | 1.56062440 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.52788920 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.52262912 |
| 37 | MP0002095_abnormal_skin_pigmentation | 1.52023598 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.51202574 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.49172905 |
| 40 | MP0000858_altered_metastatic_potential | 1.46609929 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.44297045 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.41860226 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.41740291 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.41740291 |
| 45 | MP0002723_abnormal_immune_serum | 1.41303468 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.41123730 |
| 47 | MP0002736_abnormal_nociception_after | 1.39954409 |
| 48 | MP0002398_abnormal_bone_marrow | 1.37769813 |
| 49 | MP0001944_abnormal_pancreas_morphology | 1.36881013 |
| 50 | MP0001819_abnormal_immune_cell | 1.36006754 |
| 51 | MP0001800_abnormal_humoral_immune | 1.35014340 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.34924001 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.34424248 |
| 54 | MP0005409_darkened_coat_color | 1.34080497 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.33048488 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.29781578 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.28639990 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.28574768 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.28478492 |
| 60 | MP0002132_abnormal_respiratory_system | 1.27050946 |
| 61 | MP0003303_peritoneal_inflammation | 1.26966174 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.26162923 |
| 63 | MP0005310_abnormal_salivary_gland | 1.25810570 |
| 64 | MP0001873_stomach_inflammation | 1.24553225 |
| 65 | MP0000716_abnormal_immune_system | 1.22946749 |
| 66 | MP0002722_abnormal_immune_system | 1.21564685 |
| 67 | MP0000604_amyloidosis | 1.21148191 |
| 68 | MP0002419_abnormal_innate_immunity | 1.21130239 |
| 69 | MP0005220_abnormal_exocrine_pancreas | 1.20845237 |
| 70 | MP0002429_abnormal_blood_cell | 1.18659870 |
| 71 | MP0008469_abnormal_protein_level | 1.18212526 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.18081525 |
| 73 | MP0005166_decreased_susceptibility_to | 1.16954407 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15754603 |
| 75 | MP0000343_altered_response_to | 1.15344326 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 1.13714222 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.13635716 |
| 78 | MP0005501_abnormal_skin_physiology | 1.13533008 |
| 79 | MP0001663_abnormal_digestive_system | 1.13149892 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.09295323 |
| 81 | MP0004130_abnormal_muscle_cell | 1.08580619 |
| 82 | MP0003763_abnormal_thymus_physiology | 1.07956240 |
| 83 | MP0004883_abnormal_blood_vessel | 1.06975921 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.06936912 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.06287181 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 1.05639042 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 1.04187620 |
| 88 | MP0000358_abnormal_cell_content/ | 1.03848561 |
| 89 | MP0002638_abnormal_pupillary_reflex | 1.03591118 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 1.03025216 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.02666794 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.02460413 |
| 93 | MP0001790_abnormal_immune_system | 1.01887887 |
| 94 | MP0005387_immune_system_phenotype | 1.01887887 |
| 95 | MP0004947_skin_inflammation | 1.00642130 |
| 96 | MP0000490_abnormal_crypts_of | 0.99936929 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.99466879 |
| 98 | MP0004859_abnormal_synaptic_plasticity | 0.99305502 |
| 99 | MP0004142_abnormal_muscle_tone | 0.98017636 |
| 100 | MP0003868_abnormal_feces_composition | 0.95876474 |
| 101 | MP0003690_abnormal_glial_cell | 0.95533462 |
| 102 | MP0003011_delayed_dark_adaptation | 0.94240774 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.93873772 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.92710927 |
| 105 | MP0002733_abnormal_thermal_nociception | 0.92531894 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.92143530 |
| 107 | MP0009763_increased_sensitivity_to | 0.90199740 |
| 108 | MP0003828_pulmonary_edema | 0.90125806 |
| 109 | MP0001853_heart_inflammation | 0.89820763 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.89790883 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.89768513 |
| 112 | MP0000749_muscle_degeneration | 0.89201686 |
| 113 | MP0001905_abnormal_dopamine_level | 0.89064148 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 0.88084950 |
| 115 | MP0005390_skeleton_phenotype | 0.87993373 |
| 116 | MP0000747_muscle_weakness | 0.87925787 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.87170520 |
| 118 | MP0003693_abnormal_embryo_hatching | 0.86102485 |
| 119 | MP0001851_eye_inflammation | 0.86069078 |
| 120 | MP0001764_abnormal_homeostasis | 0.85302978 |
| 121 | MP0005332_abnormal_amino_acid | 0.84941824 |
| 122 | MP0003075_altered_response_to | 0.83582474 |
| 123 | MP0008874_decreased_physiological_sensi | 0.82556081 |
| 124 | MP0005164_abnormal_response_to | 0.82432666 |
| 125 | MP0003448_altered_tumor_morphology | 0.80580353 |
| 126 | MP0008004_abnormal_stomach_pH | 0.77804124 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.68469846 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.62610396 |
| 129 | MP0002933_joint_inflammation | 0.61810136 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.61118117 |
| 131 | MP0003795_abnormal_bone_structure | 0.60886838 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60646672 |
| 133 | MP0004858_abnormal_nervous_system | 0.60586520 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.60427648 |
| 135 | MP0002653_abnormal_ependyma_morphology | 0.60115201 |
| 136 | MP0005535_abnormal_body_temperature | 0.57674156 |
| 137 | MP0000920_abnormal_myelination | 0.54343399 |
| 138 | MP0003879_abnormal_hair_cell | 0.52805972 |
| 139 | MP0002138_abnormal_hepatobiliary_system | 0.52734150 |
| 140 | MP0001542_abnormal_bone_strength | 0.51838795 |
| 141 | MP0000249_abnormal_blood_vessel | 0.47459102 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.46127692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.51123549 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.27599663 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 6.10887627 |
| 4 | Orchitis (HP:0100796) | 5.25248864 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.97806283 |
| 6 | Optic neuritis (HP:0100653) | 4.97806283 |
| 7 | Macrocytic anemia (HP:0001972) | 4.73490663 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.67595141 |
| 9 | Reticulocytopenia (HP:0001896) | 4.52471985 |
| 10 | Stomatitis (HP:0010280) | 4.42789476 |
| 11 | Pallor (HP:0000980) | 4.42279093 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.34249975 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.20755592 |
| 14 | Hepatocellular necrosis (HP:0001404) | 4.07394469 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.06557783 |
| 16 | Meningitis (HP:0001287) | 3.99151256 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.93180712 |
| 18 | Recurrent skin infections (HP:0001581) | 3.79164376 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.77127801 |
| 20 | Hepatic necrosis (HP:0002605) | 3.66267134 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 3.64106689 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.63313745 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.63313745 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57518261 |
| 25 | Encephalitis (HP:0002383) | 3.57393577 |
| 26 | Chronic otitis media (HP:0000389) | 3.48738712 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46161219 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46161219 |
| 29 | Urticaria (HP:0001025) | 3.45706517 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.42991275 |
| 31 | Progressive muscle weakness (HP:0003323) | 3.38128894 |
| 32 | Vasculitis (HP:0002633) | 3.38094711 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37104108 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.21868865 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 3.19473982 |
| 36 | Thrombocytosis (HP:0001894) | 3.18542328 |
| 37 | Acute encephalopathy (HP:0006846) | 3.15733856 |
| 38 | Gingivitis (HP:0000230) | 3.15408645 |
| 39 | Cellulitis (HP:0100658) | 3.14764220 |
| 40 | Episodic fever (HP:0001954) | 3.11474507 |
| 41 | Amyloidosis (HP:0011034) | 3.03031716 |
| 42 | Increased muscle lipid content (HP:0009058) | 3.00923907 |
| 43 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.98865593 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.96973086 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94900733 |
| 46 | Peritonitis (HP:0002586) | 2.94824247 |
| 47 | Hemoptysis (HP:0002105) | 2.93160558 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.87980404 |
| 49 | Increased CSF lactate (HP:0002490) | 2.86893536 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.83280778 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.82436992 |
| 52 | Chest pain (HP:0100749) | 2.79818324 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.78925869 |
| 54 | Increased IgM level (HP:0003496) | 2.76703723 |
| 55 | Renal Fanconi syndrome (HP:0001994) | 2.73548108 |
| 56 | Anorexia (HP:0002039) | 2.73244690 |
| 57 | Progressive macrocephaly (HP:0004481) | 2.72000084 |
| 58 | Hypochromic anemia (HP:0001931) | 2.69289558 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.68726144 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.66250818 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.65787284 |
| 62 | Gingival bleeding (HP:0000225) | 2.63079735 |
| 63 | Lactic acidosis (HP:0003128) | 2.61567145 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.60836484 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.60836484 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.60836484 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.60836484 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59602082 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59602082 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59602082 |
| 71 | Purpura (HP:0000979) | 2.59543255 |
| 72 | Progressive neurologic deterioration (HP:0002344) | 2.57254034 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.56921200 |
| 74 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.56175457 |
| 75 | Leukocytosis (HP:0001974) | 2.56053639 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.55632746 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 2.54779338 |
| 78 | Aplastic anemia (HP:0001915) | 2.50656736 |
| 79 | Recurrent viral infections (HP:0004429) | 2.48082612 |
| 80 | 3-Methylglutaconic aciduria (HP:0003535) | 2.47861211 |
| 81 | Ragged-red muscle fibers (HP:0003200) | 2.46892620 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.44074396 |
| 83 | Emotional lability (HP:0000712) | 2.43769418 |
| 84 | Arterial thrombosis (HP:0004420) | 2.43719638 |
| 85 | Pulmonary embolism (HP:0002204) | 2.43342064 |
| 86 | Loss of speech (HP:0002371) | 2.43253236 |
| 87 | Pustule (HP:0200039) | 2.40810849 |
| 88 | Abnormality of the peritoneum (HP:0002585) | 2.38734471 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38588150 |
| 90 | Increased serum lactate (HP:0002151) | 2.37784356 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 2.37533116 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.37530723 |
| 93 | Osteomyelitis (HP:0002754) | 2.37025778 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35411142 |
| 95 | Gangrene (HP:0100758) | 2.33801092 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.33679187 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.32902337 |
| 98 | Sepsis (HP:0100806) | 2.32822216 |
| 99 | Colitis (HP:0002583) | 2.32074797 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.29333332 |
| 101 | Exertional dyspnea (HP:0002875) | 2.28581893 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.27797234 |
| 103 | Microretrognathia (HP:0000308) | 2.24389256 |
| 104 | Petechiae (HP:0000967) | 2.23953634 |
| 105 | Granulocytopenia (HP:0001913) | 2.23915764 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 2.20445307 |
| 107 | Lymphopenia (HP:0001888) | 2.19920890 |
| 108 | Ketosis (HP:0001946) | 2.18509195 |
| 109 | Abnormality of T cells (HP:0002843) | 2.15514131 |
| 110 | Exercise intolerance (HP:0003546) | 2.14879251 |
| 111 | Prolonged bleeding time (HP:0003010) | 2.13758885 |
| 112 | Cerebral edema (HP:0002181) | 2.13416217 |
| 113 | T lymphocytopenia (HP:0005403) | 2.12429457 |
| 114 | Acne (HP:0001061) | 2.11139748 |
| 115 | Keratitis (HP:0000491) | 2.09743012 |
| 116 | Abnormality of the endocardium (HP:0004306) | 2.08831611 |
| 117 | Dysostosis multiplex (HP:0000943) | 2.08577311 |
| 118 | Erythema (HP:0010783) | 2.07866423 |
| 119 | IgM deficiency (HP:0002850) | 2.07179321 |
| 120 | Ketoacidosis (HP:0001993) | 2.06996380 |
| 121 | Achilles tendon contracture (HP:0001771) | 2.04833378 |
| 122 | Abnormality of T cell number (HP:0011839) | 2.04389887 |
| 123 | Hypertensive crisis (HP:0100735) | 2.04373275 |
| 124 | Spastic paraparesis (HP:0002313) | 2.04231689 |
| 125 | Acute hepatic failure (HP:0006554) | 2.02868382 |
| 126 | Recurrent abscess formation (HP:0002722) | 2.01530704 |
| 127 | Premature loss of primary teeth (HP:0006323) | 2.01356875 |
| 128 | Abnormality of T cell physiology (HP:0011840) | 2.01306360 |
| 129 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01034446 |
| 130 | Respiratory failure (HP:0002878) | 2.00896691 |
| 131 | Dicarboxylic aciduria (HP:0003215) | 2.00824367 |
| 132 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00824367 |
| 133 | Methylmalonic aciduria (HP:0012120) | 2.00824330 |
| 134 | Increased serum ferritin (HP:0003281) | 2.00385691 |
| 135 | Skin rash (HP:0000988) | 1.99767069 |
| 136 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98943617 |
| 137 | Abnormality of alanine metabolism (HP:0010916) | 1.98943617 |
| 138 | Hyperalaninemia (HP:0003348) | 1.98943617 |
| 139 | Hyperphosphaturia (HP:0003109) | 1.98371133 |
| 140 | Recurrent bacterial skin infections (HP:0005406) | 1.97909302 |
| 141 | Delayed CNS myelination (HP:0002188) | 1.97034807 |
| 142 | Microvesicular hepatic steatosis (HP:0001414) | 1.96826044 |
| 143 | Vertigo (HP:0002321) | 1.96805426 |
| 144 | Abnormality of the axillary hair (HP:0100134) | 1.96704317 |
| 145 | Abnormality of secondary sexual hair (HP:0009888) | 1.96704317 |
| 146 | Slow saccadic eye movements (HP:0000514) | 1.96655004 |
| 147 | Glomerulopathy (HP:0100820) | 1.96272285 |
| 148 | Skin ulcer (HP:0200042) | 1.96226343 |
| 149 | Late onset (HP:0003584) | 1.94735487 |
| 150 | Cortical visual impairment (HP:0100704) | 1.93569614 |
| 151 | Epistaxis (HP:0000421) | 1.93381324 |
| 152 | Microcytic anemia (HP:0001935) | 1.92488220 |
| 153 | Abnormality of reticulocytes (HP:0004312) | 1.92242751 |
| 154 | Panhypogammaglobulinemia (HP:0003139) | 1.91831970 |
| 155 | Abnormality of the Achilles tendon (HP:0005109) | 1.91516228 |
| 156 | Polyneuropathy (HP:0001271) | 1.90979790 |
| 157 | Malnutrition (HP:0004395) | 1.90909015 |
| 158 | Progressive inability to walk (HP:0002505) | 1.90683942 |
| 159 | Increased IgE level (HP:0003212) | 1.90651784 |
| 160 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90080496 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89509375 |
| 162 | Abnormality of the nasal mucosa (HP:0000433) | 1.89388940 |
| 163 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89161371 |
| 164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88815340 |
| 165 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88815340 |
| 166 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88815340 |
| 167 | Migraine (HP:0002076) | 1.88662032 |
| 168 | Optic disc pallor (HP:0000543) | 1.88314851 |
| 169 | Abnormal platelet function (HP:0011869) | 1.85866043 |
| 170 | Impaired platelet aggregation (HP:0003540) | 1.85866043 |
| 171 | Abnormal hemoglobin (HP:0011902) | 1.85764892 |
| 172 | Delusions (HP:0000746) | 1.84786556 |
| 173 | Concave nail (HP:0001598) | 1.84006039 |
| 174 | Asplenia (HP:0001746) | 1.83867279 |
| 175 | Abnormality of macrophages (HP:0004311) | 1.83787842 |
| 176 | Generalized aminoaciduria (HP:0002909) | 1.81973078 |
| 177 | Abnormality of dental color (HP:0011073) | 1.81705283 |
| 178 | Visual hallucinations (HP:0002367) | 1.81692571 |
| 179 | Seborrheic dermatitis (HP:0001051) | 1.81435091 |
| 180 | Obstructive lung disease (HP:0006536) | 1.80030165 |
| 181 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80030165 |
| 182 | Myositis (HP:0100614) | 1.77556065 |
| 183 | Broad face (HP:0000283) | 1.74907577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.63904364 |
| 2 | STK16 | 3.56392397 |
| 3 | CDK19 | 2.91359353 |
| 4 | ERN1 | 2.88204823 |
| 5 | TLK1 | 2.68586697 |
| 6 | TNK2 | 2.62145116 |
| 7 | BCKDK | 2.47563253 |
| 8 | BLK | 2.33325503 |
| 9 | CSK | 2.27325980 |
| 10 | FLT3 | 2.25543344 |
| 11 | TNIK | 2.14886786 |
| 12 | PIM2 | 2.10387479 |
| 13 | RIPK4 | 2.02451786 |
| 14 | MAPK15 | 1.95717825 |
| 15 | FES | 1.94056576 |
| 16 | DYRK3 | 1.93162537 |
| 17 | NME1 | 1.88351046 |
| 18 | ARAF | 1.84687016 |
| 19 | MAP3K12 | 1.83204942 |
| 20 | MUSK | 1.82493022 |
| 21 | PRPF4B | 1.81711734 |
| 22 | BUB1 | 1.78960664 |
| 23 | MAP2K7 | 1.74662838 |
| 24 | CAMKK2 | 1.74321258 |
| 25 | TXK | 1.73899582 |
| 26 | MAP3K3 | 1.71716591 |
| 27 | KIT | 1.67042091 |
| 28 | WEE1 | 1.61812481 |
| 29 | SCYL2 | 1.60723925 |
| 30 | MAP3K11 | 1.50541375 |
| 31 | BTK | 1.49724256 |
| 32 | MAP3K14 | 1.48379293 |
| 33 | TAOK3 | 1.47680724 |
| 34 | MAPKAPK5 | 1.44298811 |
| 35 | TEC | 1.41493263 |
| 36 | LRRK2 | 1.36809098 |
| 37 | SIK3 | 1.36095322 |
| 38 | GRK6 | 1.33889999 |
| 39 | PRKD2 | 1.32724870 |
| 40 | MAP4K1 | 1.29154394 |
| 41 | TGFBR2 | 1.20248838 |
| 42 | SYK | 1.18803206 |
| 43 | MAPKAPK3 | 1.18255698 |
| 44 | RAF1 | 1.17661449 |
| 45 | IRAK4 | 1.11660369 |
| 46 | PKN2 | 1.11275669 |
| 47 | IKBKB | 1.09468482 |
| 48 | MAP3K1 | 1.06985844 |
| 49 | ACVR1B | 1.05940928 |
| 50 | MAP3K6 | 1.04176274 |
| 51 | TAOK2 | 1.03593565 |
| 52 | DAPK3 | 1.00119225 |
| 53 | CAMK1 | 0.99918041 |
| 54 | TESK2 | 0.98611331 |
| 55 | HIPK2 | 0.97849676 |
| 56 | MAP3K7 | 0.95904654 |
| 57 | MAP2K6 | 0.90269967 |
| 58 | ITK | 0.90219735 |
| 59 | MAP3K13 | 0.90173643 |
| 60 | MARK3 | 0.89964066 |
| 61 | DYRK1B | 0.89835038 |
| 62 | JAK1 | 0.89726669 |
| 63 | ZAP70 | 0.88943478 |
| 64 | PDPK1 | 0.88350755 |
| 65 | TBK1 | 0.88152320 |
| 66 | PDK1 | 0.87083558 |
| 67 | PIK3CG | 0.85910913 |
| 68 | TRIB3 | 0.83492913 |
| 69 | IRAK3 | 0.82344861 |
| 70 | KDR | 0.81895624 |
| 71 | TYK2 | 0.81319749 |
| 72 | MAP2K2 | 0.80922490 |
| 73 | VRK1 | 0.80478980 |
| 74 | NTRK3 | 0.78196325 |
| 75 | BMPR2 | 0.77549205 |
| 76 | SIK1 | 0.76782166 |
| 77 | DAPK2 | 0.74576056 |
| 78 | IRAK2 | 0.73823655 |
| 79 | EPHB1 | 0.70554969 |
| 80 | LYN | 0.69197827 |
| 81 | MATK | 0.68540450 |
| 82 | MAP2K4 | 0.68324105 |
| 83 | CCNB1 | 0.67758492 |
| 84 | MAP3K10 | 0.66629518 |
| 85 | YES1 | 0.64149593 |
| 86 | CSF1R | 0.64037477 |
| 87 | PTK6 | 0.63891792 |
| 88 | FYN | 0.62093778 |
| 89 | FGFR4 | 0.61917944 |
| 90 | MAPK11 | 0.61314152 |
| 91 | MAP3K4 | 0.61016443 |
| 92 | KSR2 | 0.60631175 |
| 93 | MST4 | 0.60033999 |
| 94 | RPS6KB2 | 0.59669338 |
| 95 | ADRBK2 | 0.59275345 |
| 96 | MAPK4 | 0.58698075 |
| 97 | CDC42BPA | 0.58110031 |
| 98 | NLK | 0.57197596 |
| 99 | TESK1 | 0.56746605 |
| 100 | JAK3 | 0.55716241 |
| 101 | TGFBR1 | 0.53847168 |
| 102 | MAP2K3 | 0.52729245 |
| 103 | EPHA4 | 0.52115268 |
| 104 | MAP3K9 | 0.51622815 |
| 105 | UHMK1 | 0.51382603 |
| 106 | EEF2K | 0.50931245 |
| 107 | DAPK1 | 0.50797011 |
| 108 | MOS | 0.49983277 |
| 109 | HCK | 0.48781078 |
| 110 | AURKA | 0.48328610 |
| 111 | BMX | 0.48294917 |
| 112 | SIK2 | 0.48246595 |
| 113 | STK10 | 0.48141916 |
| 114 | PRKCQ | 0.48026594 |
| 115 | MARK2 | 0.47746288 |
| 116 | NEK9 | 0.47354815 |
| 117 | ILK | 0.47241685 |
| 118 | INSRR | 0.47150441 |
| 119 | RPS6KC1 | 0.47039443 |
| 120 | RPS6KL1 | 0.47039443 |
| 121 | BRAF | 0.46354205 |
| 122 | FGR | 0.45715816 |
| 123 | CAMKK1 | 0.45314875 |
| 124 | MAPK7 | 0.44642771 |
| 125 | MAP3K5 | 0.42886410 |
| 126 | EIF2AK1 | 0.42822168 |
| 127 | LCK | 0.42445843 |
| 128 | PTK2B | 0.41022161 |
| 129 | GRK7 | 0.40425249 |
| 130 | PRKCZ | 0.40293993 |
| 131 | TAOK1 | 0.39335352 |
| 132 | IRAK1 | 0.39159035 |
| 133 | RPS6KA6 | 0.38047956 |
| 134 | PRKG2 | 0.36530426 |
| 135 | IKBKE | 0.36511794 |
| 136 | STK38 | 0.36253205 |
| 137 | PRKD1 | 0.36116625 |
| 138 | MAPK12 | 0.35707728 |
| 139 | NTRK1 | 0.33936766 |
| 140 | JAK2 | 0.33649955 |
| 141 | RET | 0.32447450 |
| 142 | MAP3K2 | 0.32348148 |
| 143 | TIE1 | 0.31917372 |
| 144 | STK11 | 0.31705523 |
| 145 | PRKCD | 0.31359059 |
| 146 | PIM1 | 0.31327749 |
| 147 | PAK4 | 0.28631652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 8.15651940 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.70730993 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.66500179 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.35739721 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.20137756 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17755452 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.97939264 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.93803599 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.74288188 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.73094419 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.56702180 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53421640 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.26889999 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19367290 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15928460 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.07811869 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 2.04678624 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.96983198 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89111457 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.89004688 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.88285110 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87624344 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.84933145 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78291973 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.73144390 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.72972862 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68568344 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64743096 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.63774264 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.61192959 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59645741 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53283057 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53068333 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.52765198 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51464355 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51302507 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.50804319 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 1.50337205 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.48500621 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.48475593 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39204898 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36366225 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35864917 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31099358 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.29126489 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28777557 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.21431505 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19809849 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19529195 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19526653 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15462802 |
| 52 | Spliceosome_Homo sapiens_hsa03040 | 1.13924561 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10278462 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09756197 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09387062 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07843970 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 1.05470674 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04879944 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98059373 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93861083 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.93854517 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89282286 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.87606011 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84462631 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83881136 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.82950045 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.82919127 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80700896 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80619565 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78803712 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76509073 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.75732351 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74821514 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74444874 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74293811 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.74219573 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73231595 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72551362 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71655538 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71507153 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71355601 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69557508 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69235869 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69135370 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68659539 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67270354 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64764960 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64398808 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64121481 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63428267 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63007871 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60552299 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59235253 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57832216 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56840634 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55612942 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55093912 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54422969 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53491009 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52989195 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52249260 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.51947346 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51438150 |
| 104 | Mismatch repair_Homo sapiens_hsa03430 | 0.50953879 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50640377 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50000947 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48939588 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.47602569 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47301076 |
| 110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47182099 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45274197 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44769340 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44591464 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43568946 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42753885 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42284466 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41710852 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41189989 |
| 119 | Insulin secretion_Homo sapiens_hsa04911 | 0.40549842 |
| 120 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40233430 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39913702 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.39375879 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39306896 |
| 124 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39036559 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38760371 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.37998941 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37693587 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37332367 |
| 129 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36954381 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36499905 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36499537 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36483008 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36058167 |
| 134 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35793538 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35691101 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35505920 |
| 137 | Carbon metabolism_Homo sapiens_hsa01200 | 0.35323789 |
| 138 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35062550 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.34571727 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.33746302 |
| 141 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33734489 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33359279 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.32602838 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30559013 |
| 145 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29905377 |
| 146 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29451555 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29350683 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28154897 |
| 149 | Platelet activation_Homo sapiens_hsa04611 | 0.27191241 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27031562 |
| 151 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26937300 |
| 152 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25282892 |
| 153 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25242727 |
| 154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24840586 |
| 155 | Alcoholism_Homo sapiens_hsa05034 | 0.24755001 |
| 156 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24738300 |
| 157 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23836093 |
| 158 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22331309 |
| 159 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21368043 |
| 160 | Insulin resistance_Homo sapiens_hsa04931 | 0.20834143 |
| 161 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20437238 |
| 162 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.18666761 |
| 163 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18143154 |
| 164 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18087077 |
| 165 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.18016037 |

